A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
Clinical trial NCT06643728 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06643728
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-21
- Primary completion
- 2026-01-16
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.